Bottom line
FHLC vs IYH: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and IYH (iShares U.S. Healthcare ETF) have nearly the same top holdings — their top 25 positions are about 91% the same by weight.
But FHLC is far broader, holding 337 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.
FHLC is cheaper at 0.084% vs 0.37% — a difference of $29 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +7.0% for IYH (reporting dates differ).
Updated Nov 19, 2026
FHLC vs IYH side by side
| FHLC | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Fidelity | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.37% |
| Annual cost per $10k | $8.4 | $37 |
| 10-yr cost on $10k (prospectus) | $108 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.6% | +13.1% |
| 5-yr return (annualized) | +7.2% | +7.0% |
| 10-yr return (annualized) | +8.8% | +9.4% |
| Best quarter | +16.4% | +15.3% |
| Worst quarter | −13.1% | −12.7% |
| Net assets (fund) | $3.3B | $3.6B |
| Number of holdings | 337 | 103 |
| Portfolio turnover | 3% | 3% |
| Returns as of | Nov 30, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | IYH | Difference |
|---|---|---|---|
| 2024 | +2.6% | +3.1% | −0.5% |
| 2023 | +2.5% | +2.1% | +0.4% |
| 2022 | −5.5% | −4.4% | −1.1% |
| 2021 | +20.4% | +23.4% | −3.0% |
| 2020 | +18.1% | +15.5% | +2.6% |
| 2019 | +21.9% | +20.8% | +1.1% |
| 2018 | +5.5% | +5.9% | −0.4% |
| 2017 | +23.3% | +22.3% | +1.0% |
| 2016 | −3.3% | −2.8% | −0.5% |
| 2015 | +7.0% | +6.1% | +0.9% |
Source: Fund prospectus bar charts
Holdings overlap
20 of FHLC's top 25 holdings also appear in IYH's top 25.
| Holding | FHLC | IYH |
|---|---|---|
| Eli Lilly & Co | 13.35% | 15.11% |
| Johnson & Johnson | 8.93% | 10.17% |
| AbbVie Inc | 6.42% | 7.32% |
| UnitedHealth Group Inc | 5.44% | 6.16% |
| Merck & Co Inc | 4.66% | 5.31% |
| Thermo Fisher Scientific Inc | 3.09% | 3.52% |
| Amgen Inc | 3.00% | 3.42% |
| Abbott Laboratories | 2.66% | 3.02% |
| Gilead Sciences Inc | 2.34% | 2.66% |
| Pfizer Inc | 2.06% | 2.35% |
| Bristol-Myers Squibb Co | 1.93% | 2.20% |
| Intuitive Surgical Inc | 1.82% | 2.05% |
| Danaher Corp | 1.80% | 2.03% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.00% |
| Stryker Corp | 1.62% | 1.86% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between FHLC and IYH?
Which is cheaper, FHLC or IYH?
Should I own both FHLC and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.